Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
ATAI Life Sciences N.V. - Common Shares
(NQ:
ATAI
)
1.525
+0.005 (+0.33%)
Streaming Delayed Price
Updated: 11:13 AM EDT, Apr 24, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about ATAI Life Sciences N.V. - Common Shares
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
27
28
Next >
Psychedelic Stock Gainers And Losers From January 9, 2023
January 09, 2023
Via
Benzinga
What 4 Analyst Ratings Have To Say About ATAI Life Sciences
January 09, 2023
Via
Benzinga
atai Life Sciences Company GABA Therapeutics Announces Positive Final Results from Phase 1 Single and Multiple Ascending Dose Trial of GRX-917
January 09, 2023
From
atai Life Sciences
Via
GlobeNewswire
My "Rags-To-Riches" Portfolio For 2023: An Introduction
January 08, 2023
The performance of cannabis, psychedelic and plant-based food stocks in 2022 were just horrible; is there any way to go but up?
Via
Talk Markets
ATAI Life Sciences, Cybin Among Top Psychedelic Movers Of Today
January 06, 2023
Via
Benzinga
Atai Life Sciences' Depression Candidate Faces Trial Setback, Shares Nosedive
January 06, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 5, 2023
January 05, 2023
Via
Benzinga
atai Life Sciences' Drug Trial For Depression Fails To Deliver Expected Results, Stock Plunges
January 06, 2023
Clinical-stage psychedelics biotech atai Life Sciences (NASDAQ: ATAI) shared the results of its NYC-based subsidiary NYC-based Perception Neuroscience’s Phase 2a study of proprietary R-ketamine PCN-101...
Via
Benzinga
Dow Jumps 700 Points; S&P 500 Rises Over 2%
January 06, 2023
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 700 points on Friday.
Via
Benzinga
Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session
January 06, 2023
Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 133% to $0.3218. Swvl recently announced the commencement of a strategic review process.
Via
Benzinga
Seelos Therapeutics, Cybin Among Top Psychedelic Movers Of Today
January 04, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 2, 2023
January 02, 2023
Via
Benzinga
Nasdaq Gains 1.5%; Fate Therapeutics Shares Plunge
January 06, 2023
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 550 points on Friday.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
January 06, 2023
During Friday's trading, 71 companies set new 52-week lows.
Via
Benzinga
Psychedelic Stock Gainers And Losers From December 29, 2022
December 29, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From December 28, 2022
December 28, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From December 27, 2022
December 27, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From December 26, 2022
December 26, 2022
Via
Benzinga
Greenbrier, Fate Therapeutics, AnaptysBio And Some Other Big Stocks Moving Lower On Friday
January 06, 2023
U.S. stocks traded higher, with the Dow Jones gaining more than 500 points on Friday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Dow Rises Over 300 Points; US Adds 223,000 Jobs In December
January 06, 2023
U.S. stocks traded higher this morning, with the Dow Jones gaining more than 300 points on Friday.
Via
Benzinga
atai Life Sciences Announces Results from Phase 2a Trial of PCN-101 (R-ketamine) for Treatment-Resistant Depression
January 06, 2023
From
atai Life Sciences
Via
GlobeNewswire
Psychedelic Stock Gainers And Losers From January 3, 2023
January 03, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From December 23, 2022
December 23, 2022
Via
Benzinga
What Happened With Psychedelics In The Last Year? 11 Key News Items, The Sector's Performance & Takeaways
January 03, 2023
What a year for psychedelics!
Via
Benzinga
6 Largest Psychedelic Drug Stocks Were -20% In December
January 02, 2023
The Psychedelic Drug Stocks Index, which tracks the six largest psychedelic stocks researching the treatment of mental illnesses based on the use of one or more psychedelic substances, continued to...
Via
Talk Markets
Psychedelic Stock Gainers And Losers From December 30, 2022
December 30, 2022
Via
Benzinga
Psyched: Canada's Psychedelic Therapy Guidelines, $39M Series B For Next-Gen Drugs, Mexico's Ancestral Roots & More
December 28, 2022
Canada: Fed Guidelines For Psychedelic Therapy, Quebec Treatment Costs, Access And Magic Mushrooms Dispensaries
Via
Benzinga
Largest Psychedelic Stocks -7.6% This Week; Now -21.7% This Month
December 25, 2022
Highlighting the performance of the six stocks in our Psychedelic Drug Stocks Index, which are researching the treatment of mental illnesses using 10 different psychedelic substances.
Via
Talk Markets
Cannabis Category Performances Ranged From +0.5% To -17% Last Week
December 25, 2022
The 5 categories in the cannabis sector perform quite differently week-to-week and last week was no exception. Below is a summary of each category's performance last week, in descending order, since...
Via
Talk Markets
Dow Rises 150 Points; Mission Produce Shares Slide
December 23, 2022
U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones gaining around 150 points on Friday.
Via
Benzinga
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
27
28
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.